Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Screening for metabolic-associated fatty liver disease in type 2 diabetes patients using non-invasive scores and ultrasound: a cross-sectional study in Egypt.

  • Authors : Semeya AA; Gastroenterology and Infectious Diseases Department, Benha Teaching Hospital, Benha, El-Qalyubia, Egypt.; Hafez RSAA

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/diagnostic imaging ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/epidemiology

  • Source: BMC gastroenterology [BMC Gastroenterol] 2025 Sep 15; Vol. 25 (1), pp. 639. Date of Electronic Publication: 2025 Sep 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

Record details

×
Academic Journal

Loss of endothelial ZEB2 in mice attenuates steatosis early during metabolic dysfunction-associated steatotic liver disease.

  • Authors : Dheedene W; Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, Endothelial Cell Biology Unit, KU Leuven, Campus Gasthuisberg, Onderwijs & Navorsing 1, Herestraat 49, box 911, Leuven, 3000, Belgium.; Verhulst S

Subjects: Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/genetics ; Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/metabolism ; Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/Zinc Finger E-box Binding Homeobox 2*/deficiency

  • Source: Scientific reports [Sci Rep] 2025 Jul 02; Vol. 15 (1), pp. 23434. Date of Electronic Publication: 2025 Jul 02.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Alnustone Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Facilitating Mitochondrial Fatty Acid β-Oxidation via Targeting Calmodulin.

  • Authors : Hu S; State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, Shandong, 250012, China.; National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, Shandong, 250012, China.

Subjects: Calmodulin*/Calmodulin*/Calmodulin*/metabolism ; Calmodulin*/Calmodulin*/Calmodulin*/drug effects ; Fatty Acids*/Fatty Acids*/Fatty Acids*/metabolism

  • Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2025 Aug; Vol. 12 (31), pp. e11984. Date of Electronic Publication: 2025 Jun 05.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

Record details

×
Academic Journal

Influence of Matcha and Tea Catechins on the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-A Review of Patient Trials and Animal Studies.

  • Authors : Kosik-Bogacka DI; Department of Biology, Parasitology and Pharmaceutical Botany, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.; Piotrowska K

Subjects: Catechin*/Catechin*/Catechin*/analogs & derivatives ; Catechin*/Catechin*/Catechin*/pharmacology ; Tea*/Tea*/Tea*/chemistry

  • Source: Nutrients [Nutrients] 2025 Jul 31; Vol. 17 (15). Date of Electronic Publication: 2025 Jul 31.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The diagnostic value of MRI-PDFF in hepatic steatosis of patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis.

  • Authors : Zhang YX; Department of Gastro-Enterology, Beijing Jishuitan Hospital, Capital Medical University, No. 68, Huinanbei Road, Changping District, Beijing, 1002208, China.; Feng YP

Subjects: Magnetic Resonance Imaging*/Magnetic Resonance Imaging*/Magnetic Resonance Imaging*/methods ; Fatty Liver*/Fatty Liver*/Fatty Liver*/diagnostic imaging ; Fatty Liver*/Fatty Liver*/Fatty Liver*/pathology

  • Source: BMC gastroenterology [BMC Gastroenterol] 2025 Jul 01; Vol. 25 (1), pp. 451. Date of Electronic Publication: 2025 Jul 01.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

Record details

×
Academic Journal

Mechanism of Huanglian Wendan Decoction in ameliorating non-alcoholic fatty liver disease via modulating gut microbiota-mediated metabolic reprogramming and activating the LKB1/AMPK pathway.

  • Authors : Zhu J; School of Basic Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.; Pharmacy of College, Hunan University of Chinese Medicine, Changsha, China.

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/drug therapy ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/metabolism ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/microbiology

  • Source: PloS one [PLoS One] 2025 Sep 02; Vol. 20 (9), pp. e0331303. Date of Electronic Publication: 2025 Sep 02 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Chemical profile of Ficus lyrata bark extract and its therapeutic effect on non-alcoholic fatty liver disease via regulating oxidative stress, inflammation and hepatic lipogenesis.

  • Authors : Mousa AM; Biochemistry Department, National Research Centre, Giza, Egypt. .; Taher RF

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/drug therapy ; Plant Extracts*/Plant Extracts*/Plant Extracts*/pharmacology ; Plant Extracts*/Plant Extracts*/Plant Extracts*/chemistry

  • Source: BMC complementary medicine and therapies [BMC Complement Med Ther] 2025 Jul 19; Vol. 25 (1), pp. 280. Date of Electronic Publication: 2025 Jul 19.Publisher: BioMed Central Country of Publication: England NLM ID: 101761232 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-7671

Record details

×
Academic Journal

Role of obesity and estrogen deficiency in non‑alcoholic fatty liver disease: Insights from a mouse model.

  • Authors : Afonso-Alí A; Laboratory of Renal Function, Institute of Biomedical Technologies, University of La Laguna, Tenerife 38200, Spain.; Dicroce-Giacobini J

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/metabolism ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/pathology ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/etiology

  • Source: Molecular medicine reports [Mol Med Rep] 2025 Oct; Vol. 32 (4). Date of Electronic Publication: 2025 Jul 25.Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Concurrent nonalcoholic fatty liver disease may decrease liver fibrosis severity in patients with primary biliary cholangitis.

  • Authors : Ren W; Department of Clinical Epidemiology, Peking University People's Hospital, No.11 Xizhimen South Street, Beijing, 100044, China.; Wang Z

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/complications ; Liver Cirrhosis, Biliary*/Liver Cirrhosis, Biliary*/Liver Cirrhosis, Biliary*/complications ; Liver Cirrhosis, Biliary*/Liver Cirrhosis, Biliary*/Liver Cirrhosis, Biliary*/drug therapy

  • Source: BMC gastroenterology [BMC Gastroenterol] 2025 Jul 30; Vol. 25 (1), pp. 541. Date of Electronic Publication: 2025 Jul 30.Publisher: BioMed Central Country of Publication: England NLM ID: 100968547 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-230X

Record details

×
Academic Journal

Body muscle mass versus fat mass: gender-specific associations with NAFLD and liver fibrosis.

  • Authors : Volaklis K; Epidemiology, Medical Faculty, University of Augsburg, Stenglingstr. 2, Augsburg, 86156, Germany.; 7FIT, Cardiac Rehabilitation Center, Augsburg, Germany.

Subjects: Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/pathology ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/physiopathology ; Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/Non-alcoholic Fatty Liver Disease*/diagnostic imaging

  • Source: Lipids in health and disease [Lipids Health Dis] 2025 Sep 09; Vol. 24 (1), pp. 278. Date of Electronic Publication: 2025 Sep 09.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-511X

Record details

×
  • 1-10 of  45,255 results for ""Liver""